We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Open Science Drug Discovery Approach Targets Neurodegenerative Disease

News   Feb 18, 2019 | Original Press Release from the University of Toronto

 
Open Science Drug Discovery Approach Targets Neurodegenerative Disease

With the help of a $1.5-million grant, University of Toronto's Aled Edwards (right) and business partner Owen Roberts (left) will forgo patents and profits to tackle diseases like Parkinson's and ALS. Credit: Chris Sorensen

 
 
Advertisement
 

RELATED ARTICLES

Small Brain Device Proves Big Game Changer for Severely Paralyzed Patients

News

A tiny device the size of a small paperclip has been shown to help patients with upper limb paralysis to text, email and even shop online in the first human trial.

READ MORE

Brainstem Neurons Control Both Behavior and Misbehavior

News

A recent study reveals how gene control mechanisms define the identity of developing neurons in the brainstem.

READ MORE

Cocaine and Sucrose Rewards Recruit Different Seeking Ensembles in the Nucleus Accumbens

News

In a study using genetically modified mice, researchers found that the nucleus accumbens recruited by cocaine use are largely distinct from nucleus accumbens recruited by sucrose, or table sugar.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE